Home/Filings/4/0001225208-10-020784
4//SEC Filing

Nogales Bruce 4

Accession 0001225208-10-020784

CIK 0001405197other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 4:12 PM ET

Size

14.4 KB

Accession

0001225208-10-020784

Insider Transaction Report

Form 4
Period: 2010-09-10
Nogales Bruce
Sr. VP & GM, Plasma Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2010-09-13$1.39/sh+18,370$25,53424,291 total
  • Exercise/Conversion

    Options (right to buy)

    2010-09-10$1.39/sh7,070$9,82718,370 total
    Exercise: $1.39Exp: 2015-11-10Common Stock (7,070 underlying)
  • Sale

    Common Stock

    2010-09-10$22.95/sh7,070$162,2575,921 total
  • Exercise/Conversion

    Common Stock

    2010-09-10$1.39/sh+7,070$9,82712,991 total
  • Sale

    Common Stock

    2010-09-13$22.96/sh18,370$421,7135,921 total
  • Exercise/Conversion

    Options (right to buy)

    2010-09-13$1.39/sh18,370$25,5340 total
    Exercise: $1.39Exp: 2015-11-10Common Stock (18,370 underlying)
Footnotes (4)
  • [F1]The transaction reported was effected purusant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2010.
  • [F2]The number of shares reported consists of restricted share units representing the right to receive 5,921 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.95 to $22.975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F4]The option is fully vested and immediately exercisable.

Documents

1 file

Issuer

Talecris Biotherapeutics Holdings Corp.

CIK 0001405197

Entity typeother

Related Parties

1
  • filerCIK 0001472096

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:12 PM ET
Size
14.4 KB